Class II — Potential Health Hazard

Potential health hazard — use of or exposure to this product may cause temporary or medically reversible adverse health consequences.

McKesson Cardiology Hemo Recalled by Change Healthcare Israel Ltd. Due to users are not notified of procedure medication discrepancies...

Date: March 25, 2019
Company: Change Healthcare Israel Ltd.
Status: Terminated
Source: FDA (Device)

What You Should Do

Stop using this product immediately. Do not consume, use, or distribute it.

Return the product to the place of purchase for a full refund. If you have questions, contact Change Healthcare Israel Ltd. directly.

Affected Products

McKesson Cardiology Hemo

Quantity: 1,383 devices

Why Was This Recalled?

users are not notified of procedure medication discrepancies between the Vitals and Meds, the Procedure Notes and Patient Common Data screens in Horizon/McKesson Cardiology Hemo" (Hemo). The discrepancy may also affect administered medication data in reports generated from Hemo or the Horizon/McKesson Cardiology Physician s Report as well as customers, who have implemented an outbound interface of procedure results.

Where Was This Sold?

This product was distributed nationwide across all 50 states.

Affected (51 states)Not affected

About Change Healthcare Israel Ltd.

Change Healthcare Israel Ltd. has 2 total recalls tracked by RecallDetector.

Related Recalls

Data sourced from the FDA (Device). Last updated March 26, 2026. View original report